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The Chromatin-Remodeling Complex WINAC Targets
a Nuclear Receptor to Promoters and Is Impaired
in Williams Syndrome
factor (WSTF). WINAC has ATP-dependent chromatin-
remodeling activity and contains both SWI/SNF com-
ponents and DNA replication-related factors. The lat-
ter might explain a WINAC requirement for normal
S phase progression. WINAC mediates the recruitment
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ligand-induced transactivation processes, the com- Results
plexes containing HDAC first act to corepress transacti-
Purification of a WSTF-Containing Multiproteinvation of unliganded NRs, while upon ligand binding,
Complex Interacting with the VDRtwo HAT complexes, p160/CBP and TRRAP/GCN5, co-
Ligand Binding Domainactivate the NR function, like the other non-HAT DRIP/
To identify a coregulator complex for nuclear receptors,TRAP/SMCC coactivator complexes (Onate et al., 1995;
HeLa cell nuclear extracts were incubated with a chime-Kamei et al., 1996; Rachez et al., 1998; Gu et al., 1999;
ric VDR-DEF region protein (VDR-DEF) fused to glutathi-Yanagisawa et al., 2002).
one-S-transferase (GST), in the presence or absence ofAnother class of complexes uses ATP hydrolysis to
1,25(OH)2D3 (Figure 1A). Proteins associated with VDRrearrange nucleosomal arrays in a noncovalent manner
were collected under a milder washing condition (Ya-and render chromosomal DNA accessible for sequence-
nagisawa et al. 2002) than that in the previous reportspecific regulators (Narlikar et al., 2002). These ATP-
(Rachez et al., 1998). Proteins that interacted with VDR-dependent chromatin-remodeling complexes act on
DEF were separated by SDS-PAGE and silver stainedtranscription, DNA repair, and DNA replication and have
(Figure 1B). Mass spectrometry and the apparent molec-been classified into subfamilies based on the major ca-
ular weights of the different proteins associated withtalytic components with ATPase activity, SWI2/SNF2,
the VDR-DEF in a ligand-dependent way led to the iden-ISWI, and Mi-2 (Fyodorov and Kadonaga, 2001; Yasui
tification of several known components of the DRIP/et al., 2002). These ATPases are highly conserved from
TRAP/SMCC complex (Figure 1B), in agreement withyeast to humans and each forms a functionally similar,
previous observations (Rachez et al., 1998; Gu et al.,but distinct complex with a combination of specific com-
1999; Yanagisawa et al., 2002). One of the ligand-inde-ponents. However, the roles of most of the other compo-
pendent VDR-specific interactants was the Williamsnents, except the catalytic subunits in chromatin remod-
syndrome transcription factor (WSTF)/WBSCR9/BAZ1Beling, remain largely unknown (Narlikar et al., 2002).
(Lu et al., 1998; Peoples et al., 1998; Jones et al., 2000)Accumulating evidence revealed that both the chro-
(Figure 1B), and the WSTF protein was detected indeedmatin-remodeling complexes and the coregulatory
in native HeLa cells (Figure 1C).complexes cooperatively support transactivation of se-
By Western blotting with specific antibodies, the NR
quence-specific regulators like NRs (Glass and Rosen-
coactivators, TRAP220 and TIF2, were detected only
feld, 2000; Emerson, 2002; Narlikar et al., 2002). How-
when VDR and ER were liganded (Figure 1B). Unlike
ever, the underlying molecular basis of the functional
these factors, no ligand dependency, but VDR-selective
interplay among the complexes and the order of their interaction was found in WSTF (Figure 1B). By a GST
recruitment through regulators to the promoters in con- pull-down assay, the physical and constitutive interac-
trolling transcription at the specific local sites on the tion of recombinant WSTF in vitro was observed for
promoters are largely unknown. VDR-DEF irrespective of ligand binding, but not de-
Williams syndrome (WS) is a rare autosomal dominant tected for ER LBD (Figure 1D). In coimmunoprecipi-
hereditary disorder with multiple symptoms, including tations using the nuclear extracts of transfected MCF7
typically congenital vascular lesion, elfin face, mental cells, WSTF appeared to interact with both unliganded
retardation, and growth deficiency (Lu et al., 1998). Tran- and liganded VDR, while ligand-dependent recruitment
sient appearance of infantile aberrant vitamin D metabo- of TRAP220 and TIF2 were expectedly seen for VDR as
lism and hypercalcemia in the WS patients was also well as ER (Yanagisawa et al., 2002) (Figure 1E).
documented (Taylor et al., 1982; Garabedian et al., 1985). To purify a WSTF-containing complex, we established
This syndrome is associated with genetic deletions at a MCF7 stable transformant overexpressing FLAG-
chromosome 7q 11.23, and several candidate genes in tagged WSTF. With the nuclear extracts of the stable
the deleted regions have been mapped from their mRNA transformants, WSTF containing complexes were iso-
expression levels (Hoogenraad et al., 2002). One gene, lated by multistep purification using the GST-VDR col-
the Williams syndrome transcription factor (WSTF), has umn and an anti-FLAG affinity resin column (Figure 2A).
been suspected to be a candidate responsible for the On the glycerol density gradient (Figure 2B, upper im-
diverse WS disorders (Lu et al., 1998; Peoples et al., age), the purified complexes with a molecular weight of
1998). This possibility is raised by the fact that WSTF is greater than 670 kDa bound to the GST-VDR column
highly homologous to hACF1 as one of the WAC family and these large molecular weight fractions contained
proteins (Jones et al., 2000). Also, hACF1 is a partner WSTF, indicating that WSTF forms a stable nuclear com-
of hSNF2h (a Drosophila ISWI homolog) to form well- plex. The fractions containing FLAG-tagged WSTF were
characterized ISWI-based chromatin-remodeling com- then applied on the anti-FLAG affinity column to isolate
plexes (Poot et al., 2000). the complex.
To search a chromatin-modifying complex to account
for the ligand-independent occupancy of VDR in the Identification of a WSTF Complex
target promoters, we purified from MCF7 cells a human With the mass fingerprinting, we identified all the com-
multiprotein complex named “WINAC”. The analysis of ponents of the purified complex containing WSTF (Fig-
WINAC represents not only a molecular mechanism that ure 2C), and designated this complex as WINAC (WSTF
a direct and selective interaction of a sequence-specific Including Nucleosome Assembly Complex). WINAC sta-
regulator with a chromatin-remodeling complex, but ble formation was further supported by coimmunopreci-
also the relationship between the function of WINAC pitation with a CAF-1p150 antibody (Figure 2C). WINAC
consists of at least 13 components, but unexpectedlyand Williams syndrome disorders.
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Figure 1. Purification and Identification of Human Proteins Interacting with 1,25(OH)2D3, Unbound and Bound VDR
(A) Purification scheme for VDR interacting proteins. The eluted fraction from P11 phosphocellulose column was incubated with immobilized
GST-VDR(DEF) in the absence or presence of 1,25(OH)2D3(D3,106 M).
(B) Identification of ligand-independent and -dependent VDR interacting proteins. In the upper image, fractions were subjected to SDS-PAGE,
followed by silver staining. Total HeLa S3 nuclear extract [NE] (lane 1), a fraction eluted from the P11 column [p11] (lane 2), fractions from
GST [GST] (lane 3), unliganded- and liganded-GST-ER(DEF) columns [ER();ER()] (lanes 4 and 5), unliganded- and liganded-GST-
VDR(DEF) columns [VDR();VDR()] were examined by mass spectrometry and identified proteins are indicated at the right side of the image.
The lower image shows Western blot analysis using specific antibodies shown in the image.
(C) Protein expression in cultured cells. Western blotting with antibodies against WSTF or VDR was performed with indicated cell lines (3 
106 cells/lane).
(D) Direct and ligand-independent interaction of WSTF with VDR in vitro. WSTF, TIF2, and TRAP220 were translated in vitro and incubated
with a receptor-GST chimeric protein immobilized on glutathione-Sepharose beads in the presence or absence of the cognate ligands.
(E) 1,25(OH)2D3-independent interaction between VDR and WSTF in vivo. The upper image displays the Western blot of the total cell extracts
(Yanagisawa et al., 2002) to verify expression. The lower image shows the Western blot of the immunoprecipitates by anti-FLAG M2-affinity
resin to detect the receptor.
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Figure 2. Purification and Identification of a Human WSTF-Containing Multiprotein Complex “WINAC”
(A) Purification scheme of WINAC from MCF7 stable transformants (Yanagisawa et al., 2002).
(B) Fractionation of purified complexes on glycerol density gradient. In the lower image, Western blot analysis of each fraction using specific
antibodies is shown.
(C) The purified complex was subjected to SDS-PAGE, followed by silver staining and identified by mass spectrometry (left image). The right
image shows the reimmunoprecipitation (Re-IP) of purified WINAC by the anti-CAF-1 p150 antibody.
(D) Western blot analysis of WINAC. Western blot analysis was performed to compare nuclear extracts (lane 1), mock MCF7 (lane 2), and
FLAG-WSTF stable transformants containing WINAC (lane 3) with specific antibodies.
(E) Detection of endogenous WINAC components by Western blotting.
contains neither hSNF2h nor the components of known components share with the SWI2/SNF2-based com-
plexes (Narlikar et al., 2002). However, we could notISWI-based complexes (Figure 2C). Rather, the SWI/
SNF type ATPases (Brg1 and hBrm) and several BAF detect BAF180, which is specific to one of the hSWI/
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Figure 3. WSTF as a Platform Protein in WINAC
(A) Schematic representation of the probes used for the Far Western blotting and the GST pull-down assay. WSTF deletion mutants are
expressed as GST-chimeric proteins.
(B) Far Western blotting of the WINAC complex probed with indicated 32P-labeled GST-fused chimeric proteins. 32P-labeled GST-fused chimeric
proteins were prepared with pGEX-2TK vector (Amersham Biosciences) by PKA phosphorylation (Rachez et al., 1998).
(C) Physical interaction of WINAC components and VDR with WSTF deletion mutants in GST pull-down assay.
(D) Schematic representation of the interacting domains of WSTF.
SNF-type complexes, PBAF, which was purified and its activity with a complex of the recombinant dAcf1
identified by in vitro transcription to coactivate VDR in and dISWI proteins in a standard micrococcal nuclease
a ligand-dependent manner (Lemon et al., 2001). Inter- assay. This recombinant complex has been reported
estingly, WINAC appears to harbor three components sufficient to mobilize nucleosomes in vitro in an ATP-
(TopoII, FACTp140, and CAF-1p150) (Smith and dependent manner (Ito et al., 1997). Like the dISWI com-
Stillman, 1989; Varga-Weisz et al., 1997; LeRoy et al., plex, an ATP-dependent chromatin-assembly reaction
1998), which have not yet been found in any known ATP- was clearly induced by WINAC (compare lanes 6, 7, and
dependent chromatin-remodeling complexes. Western lane 3 in Figure 4A), indicating that Brg1/hBrm in WINAC
blotting with specific antibodies verified several WINAC serves as an ATPase for this ATP-dependent chromatin-
components (Figure 2D). Moreover, major WINAC com- remodeling process. WINAC appeared to have a chro-
ponents in a purified endogenous complex associating matin-assembly activity (data not shown) like RSF (Loy-
with VDR were detected (Figure 2E), supporting pres- ola et al., 2001).
ence of WINAC as a stable complex in native cells. We then examined the ability of WINAC to disrupt
Clear retention of VDR was detected upon the WSTF nucleosome arrays through VDR bound DNA since the
band, but not the other subunits (Figure 3B), confirming known ATP-dependent chromatin-remodeling com-
the GST-pull-down assay results (Figure 1D). The WSTF plexes are potent to recognize the nucleosomal array
fragments were trapped on not only VDR but also CAF- around the binding sites of a sequence-specific regula-
1p150 and Brg1/hBrm (Figure 3B). Such interactions tor (Ito et al., 1997; Lemon et al., 2001). By Southern
were also seen in the expected regions by the GST-pull- blot analysis with a pair of oligonucleotides complemen-
down assay (Figure 3C), suggesting that WSTF serves tary to a region in the vicinity (promoter probe) or to a
as a platform subunit to assemble components into site about 900 bp upstream (distal probe) of the GAL4
WINAC (as illustrated in Figure 3D). DBD binding sites for a chimeric VDR-DEF protein (GAL-
VDR), disruption of the nucleosome arrays in the GAL4
binding site vicinity was induced only when both VDRWINAC Is a Multifunctional ATP-Dependent
and WINAC were present (lane 4 in Figure 4B), while theChromatin-Remodeling Complex
other regions appeared unaffected in the nucleosomeWe then examined if purified WINAC exerts an ATP-
dependent chromatin-remodeling activity by comparing arrays (Figure 4B). Reflecting the VDR-specific nucleo-
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Figure 4. WINAC as an ATP-Dependent Chromatin-Remodeling Complex
(A) Chromatin-reconstitution activity of WINAC. The reacted samples were subjected to partial micrococcal nuclease digestion. The molecular
mass marker (M) is the 200 bp ladder.
(B) Chromatin disruption by WINAC is specifically VDR dependent. Oligonucleotide probe corresponds to either a sequence between the
GAL4 sites and the RNA start site (proximal probe) or 900 bp upstream of the start site (distal probe).
(C) Potentiation of VDR transactivation by WINAC in vitro. Arrows indicate specific transcripts by transcription reactions by GAL4 derivatives.
A representative result is displayed, and relative activities were calculated from three independent assays with pGI0 vector as an internal
control.
(D) WINAC functions as a chromatin-reconstitution factor during DNA replication in vitro. During DNA replication induced by SV40 T antigen
in vitro, WINAC could form chromatin with negatively supercoiled DNA. Form I, a perfect supercoiled DNA; form II, a relaxed form.
(E) WINAC formation is unchanged in S phase. MCF7 stable transformants were cultured under either normal conditions or double-thymidine
block treatments.
(F) Modulation of the cell cycle by altered WSTF expression. Left image: DNA histogram of the MCF7 cells [MCF7], WSTF stably expressing
MCF7 cells [WSTF stable] and MCF7 cells transfected with WSTF-RNAi [i-WSTF]. Right image: BrdU incorporation during S phase of the
MCF7 cells transfected with RNAi from the indicated proteins during double-thymidine treatment. After the final release (time 0), cells were
collected every 2 hr, for up to 8 hr. The average values of triplicate analyses are shown.
some disruption by WINAC among tested receptors (Fig- stages, even when blocked at S stage by double-thymi-
dine treatments (Fujita et al., 1996) (Figure 4E). Manipula-ure 4B), ligand-induced transactivation in vitro was po-
tentiated by WINAC for VDR, but for neither ER nor tion of WSTF expression by WSTF-RNAi expression (El-
bashir et al., 2001) resulted in alterations in the cell cyclePPAR (Figure 4C).
(left images in Figure 4F). Particularly, DNA synthesis
was clearly lowered by RNAi expression of either WSTFWINAC Function during DNA Replication
or Brg1/hBrm ATPases (right image in Figure 4F). Thus,The WINAC function in DNA replication (Smith and
these findings suggest that WINAC plays a role in chro-Stillman, 1989; Varga-Weisz et al., 1997) was addressed
matin remodeling during DNA replication.by reconstituting chromatin structure upon newly repli-
cated DNA by an in vitro assay. WINAC, like the reported
CAF-1 histone chaperone complex (see lanes 7 and 8 in WSTF Coactivated Ligand-Induced
Transactivation Function of VDRFigure 4D), could facilitate forming chromatin structure
with negatively supercoiled DNA on newly replicated Next, we investigated if WSTF potentiates the ligand-
induced transactivation of VDR in MCF7 cells by tran-DNA through nucleosome arrangement (Smith and
Stillman, 1989) (Figure 4D). Moreover, WINAC complex sient expression analysis. 1,25(OH)2D3 (109 M) was
effective to induce VDR AF-2 transactivation function.formation was detected irrespective of the cell-cycle
RE
RA
CT
ED
Nuclear Receptor Promoter Targeting by WINAC
911
WSTF coactivated this ligand-induced AF-2 function of Impaired Transactivation Function of VDR Was
Recovered by WSTF OverexpressionVDR, but not ER (compare lanes 3 and 4 with 23 and
24 in Figure 5A). Both Brg1 and hBrm were potent to in Williams Syndrome Patients
Together with these observations, the typical pheno-enhance the transactivation functions of VDR and ER
(compare lanes 9 and 12 with lane 2 for VDR; lanes 29 types of the WSTF gene-deleted WS patients (Taylor et
al., 1982; Garabedian et al., 1985) prompted us to as-and 32 with lane 22 for ER in Figure 5A) as previously
reported (Chiba et al., 1994; DiRenzo et al., 2000; Shang sume that a lowered WINAC function caused by reduced
WSTF expression may result in aberrant chromatin re-et al., 2000; Belandia et al., 2002). Interestingly, such
coactivator-like activity of WSTF was selective for VDR, modeling, leading to diverse abnormalities, including
abnormal vitamin D metabolism and hypercalcemia.and not detected for ER, even in the presence of Brg1/
hBrm (see lanes 30 and 33 in Figure 5A). Considering WSTF and VDR skin expression (Yoshizawa
et al., 1997), we first assessed the ligand-induced trans-To confirm such a coactivator-like function of WSTF
for VDR, the ligand-induced transactivation function of activation function of VDR in skin fibroblast cells derived
from three normal and three WS patients, in which theVDR was assessed 40 hr after the RNAi transfection and
was severely attenuated nearly to basal transcription region covering the WSTF gene is deleted in one chro-
mosome 7 allele, as representatively shown in patientlevels (lanes 7 and 8 in Figure 5A). Interestingly, WSTF-
RNAi expression was found to also abrogate the VDR #1 by FISH analysis (Figure 6A). Northern blot analysis
unmasked the WSTF expression levels were clearly low-coactivation of the VDR transcriptional activity by the
known NR coactivators, such as TRAP220 and TIF2 ered (50%) in the WS patients (Figure 6B). By a tran-
sient transfection assay in fibroblast cells, we found(lanes 16 and 18 in Figure 5A). Similarly, RNAi expression
resulted in a loss of the coactivator-like function of reduced transactivation function of VDR in the WS pa-
tient cells (Figure 6C). Consistent with the impaired func-WSTF for VDR when intact VDR/RXR heterodimer was
bound to a naturally occurring positive vitamin D re- tion of VDR in the WS cells, the ChIP analysis showed
robust reduction in targeting of VDR, the WINAC compo-sponse element (VDRE) derived from the human 1,25-
dihydroxyvitamin D3 24-hydroxylase [24(OH)ase] gene nents, and the coactivators to the 24(OH)ase VDRE
(lanes 9 and 10 in Figure 6E), in agreement with thepromoter (Chen and DeLuca, 1995) (Figure 5C). ChIP
analysis revealed that VDR and the WINAC components MCF7 cell results (Figure 5B).
Most strikingly, WSTF expression by an adenoviruswere constitutively associated with the promoter irre-
spective of ligand binding. In the contrast, ligand- vector (Kitagawa et al., 2002) could rescue the reduced
responsiveness of 24(OH)ase gene induction byinduced occupancy in the promoter was seen in
TRAP220 and TIF2 with ligand-induced histone H4 acet- 1,25(OH)2D3 for 12 hr in the WS skin fibroblasts (com-
pare lane 3 with 4 in Figure 6D), with the impaired pro-ylation (compare lane 3 with 4 in Figure 5B), though
the ligand-induced TRAP220 and TIF2 occupancy was moter targeting of the WINAC components and unli-
ganded recoveries in VDR to the 24(OH)ase promotercyclic (data not shown) as expected from previous re-
ports (Shang et al., 2000). Such ligand-dependent and (see lane 11 in Figure 6E), and the impaired ligand-
induced recruitment of the NR coactivators (see lane 12-independent recruitments of factors to the promoter
were robustly attenuated by WSTF-RNAi expression (lane in Figure 6). Thus, these findings suggest that at least
a part of the endocrine disorders found in the WS pa-5 in Figure 5B).
As the VDR/RXR heterodimer also represses tran- tients are related to VDR malfunction caused by the
lowered WINAC function, which is due to lower WSTFscription in a ligand-dependent manner through nega-
tive VDRE (nVDRE), the action of WSTF in the ligand- expression.
The WSTF transcript during embryogenesis was notinduced transrepression was examined in a naturally
occurring nVDRE in human 25-hydroxyvitamin D3 detected by Northern blotting, but detectable by RT-
PCR (Figure 7A). By whole mount in situ staining (Sekine1-hydroxylase [1(OH)ase] (Murayama et al., 1998).
ChIP analysis uncovered that VDR and WINAC appear et al., 1999) at 9.5 dpc, the WSTF transcript appeared
to be ubiquitously expressed (data not shown), but itsto land on the nVDRE in a ligand-independent manner,
while ligand-induced (compare lane 8 with 9 in Figure expression pattern became limited and partially over-
lapped with mouse Brg1 and BAF155 (Srg3) expression5B), but cyclic (data not shown) recruitments of N-CoR
(Bultman et al., 2000; Kim et al., 2001) as evident at 11.5and HDAC2 were observed. Ligand-dependent repres-
dpc (Figure 7B). Surprisingly these expression patternssion was exaggerated by WSTF overexpression (lanes
seem different from that of mouse Snf2h (Lazzaro and3 and 4 in Figure 5D), but attenuated again by WSTF-
Picketts, 2001), particularly at brain. These results mayRNAi expression (lanes 5 and 6 in Figure 5D). Thus, it
suggest a specific role of WINAC during embryogenesis,is likely that WINAC association with VDR facilitates
which may account for the diverse abnormalities in thetargeting of a putative corepressor complex to the
WS patients.nVDRE. The WINAC function in the native VDR target
gene promoters and the endogenous gene expressions
of 24(OH)ase and 1(OH)ase were further confirmed by Discussion
the impaired 1,25(OH)2D3 responsiveness by the
WSTF ablation (Figure 5E). Thus, these findings point out Purification and Identification of a Human
that WINAC rearranges the nucleosome array around the Multiprotein Complex Containing WSTF, WINAC
positive and negative VDREs, thereby facilitating the WINAC contains known components of the hSWI/SNF-
coregulatory complexes accessible to VDR for further type complexes, including two major ATPase subunits,
Brg1 and hBrm (Figure 2C). However, by our purificationtranscription control.
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Figure 5. Ligand-Dependent Promoter Targeting of Coregulators through WINAC-VDR Association
(A) VDR-specific facilitation of co-activator accessibility by WINAC. MCF7 cells were transfected with the expression vectors of a luciferase
reporter plasmid containing the GAL4 upstream activation sequence (UAS) [17mer(2)] driven by the -globin promoter (0.5 g). PML-CMV
(2 ng); GAL4-DBD-VDR-DEF (0.2 g); GAL4-DBD-ER DEF (0.2 g); pDNA3-FLAG-WSTF (; 0.1 g: ; 0.3 g); pSV-Brg1 (0.2 g); pSV-
hBrm (0.2 g); pcDNA3-TRAP220 (0.3 g); pcDNA3-TIF2 (0.3 g); siRNA (; 0.1 g: ; 0.2 g) of WSTF-RNAi; or control RNAi or their
combinations were transfected as indicated in the images in the absence or presence of ligand (109 M). Bars in each graph show the fold
change in luciferase activity relative to the activity of the receptor transactivation in the presence of ligand.
(B) ChIP analysis on the 24(OH)ase promoter and 1(OH)ase promoter of WSTF stable transformants. Soluble chromatin was prepared from
WSTF stable transformants treated with D3 (109 M) for 45 min and immunoprecipitated with indicated antibodies.
(C and D) The coregulator-like actions of WSTF on the naturally occurring positive and negative vitamin D response elements. MCF7 cells
were transfected with the expression vectors of either the luciferase reporter plasmid containing a human 24(OH)ase promoter harboring a
canonical positive VDRE or a human 1(OH)ase promoter containing a negative VDRE and the factors shown in (A) or together with pcDNA3-
N-CoR (0.3 g), pcDNA3-HDAC2 (0.3 g).
(E) WSTF-mediated regulations of endogenous genes by VDR. RT-PCR analysis of MCF7 cells was performed 12 hr after the induction by D3
(109 M) (Yanagisawa et al., 2002).
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Figure 6. Impaired VDR Function in the Fibroblasts of Williams Syndrome Patients Was Recovered by WSTF Overexpression
(A) Fluorescence in situ hybridization of WS patient 1, confirming a deletion of one copy of the WSTF gene. The black arrowhead indicates
D7S427 gene locus and the white arrowhead for WSTF gene. D7S427 was used for a chromosome 7 marker and cosmid full-length WSTF
for WSTF gene probe.
(B) Reduced WSTF expression levels in WS skin fibroblasts. The indicated genes were examined for expression by Northern blotting with
GAPDH expression as an internal control (Yanagisawa et al., 2002). Densitometric analysis of the relative expression level of WSTF versus
GAPDH is shown in the lower image.
(C) VDR transactivation functions were impaired in the skin fibroblasts of the WS patients. Fibroblasts from controls and patients were
transfected with the expression vectors as described in Figure 5A and the receptor function was tested.
(D) WSTF overexpression recovered the impaired responsiveness to vitamin D during 24(OH)ase gene induction. Patient’s skin fibroblasts
were transfected with an adenovirus expressing FLAG-WSTF, and treated with 1,25(OH)2D3 (109 M) for 12 hr. Total RNA was subjected to
RT-PCR analysis of 24(OH)ase expression.
(E) Impaired promoter targeting of VDR, coregulators, and WINAC components in fibroblasts from WS patients was rescued by WSTF overexpression.
ChIP assays of the patient skin fibroblasts were performed with adenovirus expressing FLAG-WSTF as described in Figure 5B.
(F) Hypothesis of the cause of hypercalcemia in Williams syndrome patients.
methods we could detect neither the PBAF complex complex that promotes chromatin-dependent transcrip-
tional elongation with an ISWI-type complex (LeRoy etnor its specific component (BAF180). Moreover, by our
purification, no ISWI-based complex was detectable al., 1998). From the observed WSTF interactions with the
other subunits in vitro (Figures 3A–3D), WSTF appears toeven in the glycerol gradient fractions containing com-
plexes with expected molecular weights. These obser- serve as a core protein to form an SWI2/SNF2-based
complex, generating a subclass of the ATP-dependentvations are also different from a report that WSTF forms
a hISWI-based chromatin-remodeling complex (Boz- chromatin-remodeling complex with DNA replication-
related factors. Taken together, WSTF may serve as ahenok et al., 2002). Confirming that hISWI (hSNF2h) ex-
pression did not affect the VDR transactivation function dual platform protein capable of forming both SWI/SNF-
and ISWI-type chromatin-remodeling complexes by dis-(Figures 5A and 5B), the combination with ISWI-based
complex components looks to deter WSTF from the VDR tinct subunit combinations, but only the SWI/SNF-type
WINAC selectively assists VDR function through a physi-interaction.
Of note, WINAC harbors three components, which cal interaction.
have not yet been found in the ATP-dependent chroma-
tin-remodeling complexes. Two factors (CAF-1p150 and WINAC Is a Chromatin-Remodeling Complex
Specific and more efficient targeting of VDR throughTopoII are integrated in the complexes serving roles
in DNA replication (Smith and Stillman, 1989; Varga- WINAC to the VDREs was supported from functional
analyses of the purified WINAC in vitro. In this respect,Weisz et al., 1997), while FACT p140 is involved in a
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Figure 7. Spatiotemporal Expression Pat-
terns of WSTF during Mouse Embryogenesis
(A) RT-PCR analysis of mouse WSTF, Brg1,
BAF155 (Srg3), Snf2h, Hoxc-5, and -actin
gene expression. Embryos were dissected at
the indicated times (7.5 dpc to 18.5 dpc).
Samples were normalized by dilution to give
equivalent signals for -actin.
(B) Whole mount in situ hybridization analysis
of mouse WSTF, Brg1, BAF155 (Srg3), Snf2h,
and Hoxc-5 (negative control) expression at
11.5 dpc (Scale bar: 2 mm. Sense control
probes were also hybridized and no signal
was detected; data not shown).
WINAC subunit configuration is of interest to be clarified ER transactivation (Chiba et al., 1994; DiRenzo et al.,
2000; Belandia et al., 2002), overexpression of WSTFfor defining the function of each component. A recent
report has revealed that the chromatin-remodeling ac- and the ATPase subunits as well could coactivate the
ligand-induced VDR transactivation as either a GAL4tivity of the dISWI-based complex requires multiple Acf1
motifs to nonspecifically anchor DNA through its WAC DBD chimeric protein or heterodimer with RXR (Figures
5A and 5C). VDR coactivation by the ligand-dependentmotifs, and to directly interact with ISWI through the
DDT domain (Fyodorov and Kadonaga, 2002). In addition NR coactivators (TIF2 and TRAP220) was abrogated by
WSTF-RNAi expression (Figure 5A). However, neitherto a core subunit role of WSTF, multiple functions as a
pivotal factor to conduct the WINAC function could be such coactivator-like WSTF actions nor reduced coacti-
vation by NR coactivators by the WSTF-RNAi expressionfurther speculated from the conservation of several mo-
tifs that are shared with the other WAC family proteins, was detected for ER (Figure 5A) and the other receptors
tested (data not shown), supporting the observed directlike hACF1 (Jones et al., 2000). Moreover, functions of
the bromodomain and PHD finger motif in WSTF remain and selective interaction of WSTF with VDR among NRs
(Figure 1D). Moreover, WSTF overexpression potenti-to be established in the promoter targeting and chroma-
tin remodeling (Hassan et al., 2002; Schultz et al., 2002). ated the ligand-induced transrepression of VDR on the
1(OH)ase negative VDRE (Figure 5D), where an ablation
of endogenous WSTF by RNAi expression led to a signifi-Promoter Targeting of VDR by WINAC
and Cooperative WINAC Function cant reduction in ligand-induced corepressor recruit-
ment (lane 10 in Figure 5B). Thus, ligand-independentwith the Coregulator Complexes
Similar to the reported coactivator-like actions of the association of WINAC and VDR in the VDR target pro-
moters appears to facilitate the local nucleosomal arraySWI2/SNF2 ATPases and BAF57 for the ligand-induced
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accessibility for ligand-dependent coregulators, follow- ing to speculate that the significantly reduced WINAC
levels in WS patients transiently cause impaired functioning histone tail modifications by the recruited coregula-
tor complexes (Hassan et al., 2002). It was recently re- in VDR and other unidentified factors, leading to the
transient appearance of infantile aberrant vitamin D me-ported that only when ligand is bound to ER, all of the
ER p160/CBP HAT coactivator complex and human tabolism and consequently, hypercalcemia (Taylor et al.,
1982; Garabedian et al., 1985). These findings togetherSWI/SNF-type complexes are targeted to the ER target
promoters, although such ligand-induced occupancy of suggest that a normal WSTF dose in the cells is neces-
sary to support normal activities of VDR and presumablyER and coregulator in the promoters appears in a cyclic
fashion (Shang et al., 2000; Belandia et al., 2002). Such of some other regulators.
WSTF expression patterns during mouse embryogen-ligand-induced assembly of the SWI/SNF-type com-
plexes with NRs through the p160/CBP complex might esis overlap with those of the common components of
WINAC (Bultman et al., 2000; Kim et al., 2001), but ap-be a common mechanism for ligand-dependent tar-
geting of NRs to the cognate promoters (Glass and Ro- pear more limited. In contrast, the more restricted ex-
pression pattern was detected in mouse ISWI (Snf2h)senfeld, 2000).
Unlike NRs such as ER and AR (Belandia et al., 2002; (Lazzaro and Picketts, 2001) (Figure 7B). It is therefore
possible to suggest that specific roles of WINAC amongShang et al., 2002), VDR appears from ChIP analysis
(Figure 5B) to be selectively targeted through WINAC to the other chromatin-remodeling complexes exert in a
more spatiotemporal manner and support organogene-the promoters without ligand-induced activation of VDR
function or following recruitment of coregulator com- sis of several selected tissues during embryogenesis
through chromatin remodeling for, at least, transcriptionplexes. WINAC targeting to the promoters appears not
to require specific histone tail modifications by coregu- and DNA replication. Therefore, the WS patients may
suffer a wide spectrum of disorders in certain organs.lators. Thus, it is likely that WINAC associating on pro-
moters escort VDR for its recognition and specific bind- Thus, this study suggests that the Williams syndrome
disorders are caused, at least in part, by WINAC dys-ing to VDREs, through nucleosomal mobilization by
WINAC, presumably cooperating with the other chroma- function as a chromatin-remodeling disease.
tin complexes (Lemon et al., 2001). Alternatively, once
Experimental ProceduresVDR happens to bind VDREs during nonspecific chro-
matin remodeling, WINAC might be acquired to VDR
Plasmids and Antibodiesupon the promoters to engage in local nucleosome reor-
Chimeric GST proteins of GAL4 DBD (1–147 aa) fused with Rat
ganization. The latter possibility coincides well with a VDR-DEF and WSTF deletion mutants were expressed in pGEX-2TK
recent report about a sequence-specific regulator, (Pharmacia Biotech). The promoter region of 1,25-dihydroxyvita-
min D3 24-hydroxylase (367 to 0) and 25-hydroxyvitamin D3SATB1 (Yasui et al., 2002). As a result, the local chroma-
1-hydroxylase (889 to30) were inserted into the pGL3 vectortin structure near VDREs may transit into an active chro-
(Promega) driven by a thymidine kinase (tk) promoter (Chen andmosomal state that appears competent for receipt of
DeLuca, 1995; Murayama et al., 1998; Yanagisawa et al., 2002).both the coactivator complexes and the corepressor
Rabbit polyclonal antipeptide antiserum was prepared by Sawady
complexes (Figures 5C and 5D) dependent on the VDRE technology against KLQSEDSAKTEEVDEEKK, which is near the hu-
sequences and the tertiary positions of DNA-bound man WSTF C terminus.
VDR. This is not consistent with recent observations
that the chromatin-remodeling complexes are recruited Purification and Separation of VDR-Associated Complexes
For WINAC purification, the nuclear extracts of the MCF7 stableonly after acetylation/deacetylation of histone tails by
transformant were prepared by the same method as HeLa nuclearthe coregulatory complexes (Hassan et al., 2002). How-
extracts (Rachez et al., 1998; Kitagawa et al., 2002; Yanagisawa etever, the orders of the complex targetings are supposed
al., 2002). Then, they were bound to the GST column [GST], and
to be dependent on the regulator type and the promoter 1,25(OH)2D3-unbound GST-VDR column [GST-VDR(D3-)]. The
context (Lomvardas and Thanos, 2002; Soutoglou and complexes bound to the ligand-unbound VDR were eluted with 15
mM reduced glutathione in elution buffer (50 mM Tris-HCl [pH 8.3],Talianidis, 2002).
150 mM KCl, 0.5 mM EDTA, 0.5 mM PMSF, 5 mM NaF, 0.08% NP-
40, 0.5 mg/ml BSA, and 10% glycerol). Next, they were layered onWilliams Syndrome Is a Chromatin-Remodeling
top of a 4.5 ml linear 100%–40% glycerol gradient in the GST binding
Factor Disease? buffer and centrifuged for 16 hr at 4C at 40,000 rpm in a SW40
We found that the ligand-induced transactivation func- rotor (Beckman). Protein standards were ovalbumin (44 kDa),
-globulin (158 kDa), and thyroglobulin (667 kDa). Finally, the frac-tion of VDR is impaired in the skin fibroblast cells of all
tions containing WSTF and VDR were collected and loaded onto athree tested patients, in whom the regions covering the
2.5–5 ml anti-FLAG M2 resin column (Sigma). After washing withWSTF gene locus at the chromosome 7q11.23 are het-
binding buffer, the bound proteins were eluted by incubation for 60erozygously deleted. Such impaired VDR function
min with 10–15 ml of the FLAG peptide (0.2 mg/ml) (Sigma) in binding
should not lead to severe defects in vitamin D actions buffer.
in adults, since the adult VDR heterozygote mice
(VDR/) and the heterozygous carrier patients of the In Vitro Chromatin Reconstitution and Disruption Assay
Chromatin reconstitution and disruption reactions were performedhereditary vitamin D-dependent type II rickets caused
essentially as previously described (Ito et al., 2000) using su-by VDR inactivation exhibited no overt abnormality in
percoiled plasmid DNA. A standard reaction contained plasmid (0.4calcium and vitamin D metabolism, though VDR is a
g), purified core histones from Drosophila embryos (0.33 g), puri-major regulator in those metabolisms (Yoshizawa et al.,
fied recombinant dNAP1 (2.8g) [dNAP1], purified recombinant ACF
1997). However, during growth, the mineral intakes must (40 ng) [dACF], purified WINAC (100 ng) [WINAC], ATP (3 mM), and
be greater than their excretions through the actions of the ATP-regenerating system (30 mM phosphocreatine and 1mg/
ml creatine phosphokinase). For the chromatin-disruption assay,calciotropic hormones, including vitamin D. It is tempt-
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chromatin was reconstituted with DNA, pGIE0 (containing the GAL4 Received: December 30, 2002
Revised: May 16, 2003binding site) and purified histones by salt dialysis, and GST-GAL4
fusion proteins [e.g., GAL-VDR] mediated disruption of nucleosome Accepted: May 28, 2003
Published: June 26, 2003arrays was analyzed by micrococcal nuclease digestion-Southern
blot analysis.
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